文献速递头颈部肿瘤放疗

法国多中心回顾性DRAKAR研究:鼻咽癌放疗营养与消化道影响评估

Evaluation of the nutritional and digestive impact of irradiation in nasopharyngeal cancers: the French multicenter retrospective DRAKAR study.
PubMed 文献 · Clin Transl Radiat Oncol · 2026-10-06

DRAKAR研究在法国5个中心回顾2015—2024年接受根治性放疗的124例原发性鼻咽癌患者,评估预防性肠内营养对体重变化的影响。放疗结束时平均体重变化为-6.45%,预防性肠内营养与治疗后体重稳定相关,但与住院或生存改善无关;年龄<55岁是营养不良唯一显著相关临床因素。

要点

  • 放疗结束时平均体重变化为-6.45%,治疗前营养不良占8%,治疗1个月后升至35.5%。
  • 55.6%患者使用肠内营养,其中16.1%为预防性使用,与治疗后体重稳定相关。
  • 预防性肠内营养未与住院或生存改善相关,年龄<55岁是营养不良唯一显著临床因素。

核心结论

  • 在鼻咽癌根治性放疗患者中,预防性肠内营养与治疗后体重变化稳定相关,但与住院或生存改善无关。

研究设计与样本

  • DRAKAR为法国5个中心开展的回顾性多中心研究,纳入2015—2024年接受根治性放疗(可伴同步化疗)的原发性鼻咽癌患者124例。

主要发现

  • 124例患者中59.7%为未分化癌(UCNT)、40.3%为鳞状细胞癌,放疗结束时平均体重变化为-6.45%。
  • 治疗前营养不良占8%,治疗1个月后35.5%患者存在营养不良。
  • 55.6%患者使用肠内营养,其中16.1%为预防性使用,预防性肠内营养与治疗后体重变化稳定相关。
  • 年龄<55岁是营养不良唯一显著相关临床因素,未发现与毒性、剂量学或治疗特征相关。
  • 预防性肠内营养与住院或生存改善无关。

关键数值与推荐

  • 中度营养不良定义为1个月内体重下降5%,重度营养不良定义为1个月内体重下降10%。

临床怎么用

  • 对鼻咽癌根治性放疗患者可考虑预防性肠内营养以稳定治疗后体重,但需注意适应证混杂,不能据此推断可减少住院或改善生存。

局限性

  • 研究为回顾性设计,预防性肠内营养存在适应证混杂,结论需谨慎解读,尚需前瞻性研究确认其获益与最佳适应证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Radiotherapy for nasopharyngeal cancers is associated with frequent digestive and nutritional toxicities, weight loss (WL), and malnutrition, criteria of poor tolerance and poor prognosis. The primary objective of DRAKAR was to evaluate the effect of prophylactic enteral nutrition (EN) on weight change (WC) during, at the end of, and after radiotherapy in patients with nasopharyngeal cancer from a non-endemic French population. MATERIALS AND METHODS: DRAKAR is a retrospective, multicenter study conducted in five French centers. Patients received radiotherapy with curative intent, with or without concurrent chemotherapy, for primary nasopharyngeal cancer between 2015 and 2024. The primary endpoint was WC according to nutritional support modality at the end of radiotherapy. Secondary endpoints included rates of moderate and severe malnutrition (5% or 10% WL in one month for moderate and severe malnutrition), grade ≥ 3 toxicities, dosimetry parameters (volumes, particles), use and duration of EN and parenteral nutrition, prolonged radiotherapy due to treatment interruption, hospitalizations, and overall survival. RESULTS: Among the 124 patients analyzed (59.7% UCNT, 40.3% squamous cell carcinoma), mean WC was -6.45% at the end of radiotherapy. At one month, 35.5% were malnourished, compared with 8% before treatment. EN was used in 55.6% of patients, including 16.1% prophylactically. Prophylactic EN was associated with stabilization of WC after treatment. Regarding malnutrition, age < 55 years was the only significant clinical factor associated with its occurrence, with no association found with toxicity, dosimetric, or therapeutic characteristics. CONCLUSION: In patients treated for nasopharyngeal cancer, prophylactic EN was associated with post-treatment WC stabilization but not with hospitalization or improved survival. Given potential confounding by indication, these findings should be interpreted cautiously, and prospective studies are needed to confirm the benefit and optimal indications for prophylactic EN.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Cochin T, Le Guévelou J, Thariat J, et al. Evaluation of the nutritional and digestive impact of irradiation in nasopharyngeal cancers: the French multicenter retrospective DRAKAR study. Clin Transl Radiat Oncol. 2026. PMID: 42892922. doi:10.1016/j.ctro.2026.101303

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。